Author: S. C. Springmeyer1, J. R. Jett2; Medical, Biodesix, Boulder, CO, United States, National Jewish Health, Denver, CO, United States
Home
ATS2021
We are pleased to share details on the presentations and new data that will be presented at ATS 2021.
Registered attendees, please visit our booth in the virtual exhibit hall to learn more.
Nodify Lung™ testing consists of two blood-based proteomic tests (the Nodify CDT™ & Nodify XL2® tests) to help physicians reclassify risk of cancer and aid in stratifying patients into distinct nodule management pathways: intervention or surveillance.
Biodesix Lung Reflex® testing consists of the GeneStrat® tumor profiling test and the VeriStrat® immune profiling test to provide physicians with timely molecular results to facilitate treatment decisions for patients with non-small cell lung cancer.
We provide biopharmaceutical companies with end-to-end diagnostic services inclusive of diagnostic research and feasibility, assay development, clinical trial testing, and commercialization of companion diagnostics.